Subtopic Deep Dive

Epigenetic Regulation by Chromatin Remodelers
Research Guide

What is Epigenetic Regulation by Chromatin Remodelers?

Epigenetic regulation by chromatin remodelers involves ATP-dependent enzymes that reposition nucleosomes to control DNA accessibility, histone variants, and methylation patterns in cancer epigenomes.

Chromatin remodelers like SWI/SNF complexes, including ARID1A and SMARCB1 subunits, are frequently mutated across cancers such as ovarian clear-cell carcinoma and endometrial carcinoma (Wiegand et al., 2010; Getz et al., 2013). These mutations disrupt gene expression by altering chromatin structure genome-wide. Over 20 papers from the provided list highlight remodeler roles in medulloblastoma, leukemia, and rhabdoid tumors.

Curated Papers

Key Challenges

Why It Matters

Mutations in SWI/SNF remodelers like ARID1A occur in 50% of endometriosis-associated ovarian carcinomas, marking early oncogenic events detectable in preneoplastic lesions (Wiegand et al., 2010). SMARCAD1 ATPase activity silences retroviruses in stem cells, with loss linked to embryonic dysregulation relevant to pediatric cancers (Sachs et al., 2019). EZH2 inhibition regresses SMARCB1-deficient rhabdoid tumors, validating remodeler dependencies for targeted epi-drugs (Knutson et al., 2013). SWI/SNF alterations appear in ~20% of human cancers, enabling precision therapies (Shain and Pollack, 2013).

Key Research Challenges

Mapping remodeler-histone interactions

Genome-wide identification of specific remodeler-histone contacts remains limited by low-resolution techniques. Hargreaves and Crabtree (2011) detail ATP-dependent mechanisms but note gaps in subunit-specific binding. Recent studies like Sachs et al. (2019) use sequencing yet struggle with dynamic interactions.

Linking mutations to epigenetic states

Distinguishing driver from passenger mutations in heterogeneous tumors challenges causal inference. Getz et al. (2013) integrated multi-omics in endometrial cancers but causality requires functional validation. Robinson et al. (2012) found subgroup-specific medulloblastoma mutations needing epigenetic correlation.

Developing remodeler-targeted therapies

Compensatory pathways upon remodeler loss, like EZH2 upregulation in SMARCB1 mutants, complicate inhibition (Knutson et al., 2013). Shain and Pollack (2013) catalog ubiquitous SWI/SNF mutations but note variable drug sensitivities. Clinical translation lags due to complex complex assembly (Wang et al., 1996).

Essential Papers

Integrated genomic characterization of endometrial carcinoma

Gad Getz · 2013 · Nature · 5.6K citations

We performed an integrated genomic, transcriptomic and proteomic characterization of 373 endometrial carcinomas using array- and sequencing-based technologies. Uterine serous tumours and ∼25% of hi...

SMARCAD1 ATPase activity is required to silence endogenous retroviruses in embryonic stem cells

Parysatis Sachs, Dong Ding, Philipp Bergmaier et al. · 2019 · Nature Communications · 2.4K citations

<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas

Kimberly C. Wiegand, Sohrab P. Shah, Osama M. Al‐Agha et al. · 2010 · New England Journal of Medicine · 1.6K citations

These data implicate ARID1A as a tumor-suppressor gene frequently disrupted in ovarian clear-cell and endometrioid carcinomas. Since ARID1A mutation and loss of BAF250a can be seen in the preneopla...

The whole-genome landscape of medulloblastoma subtypes

Paul A. Northcott, Ivo Buchhalter, A. Sorana Morrissy et al. · 2017 · Nature · 1.1K citations

Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose debilitating effects on the developing child, and highlight the need for molecularly targeted treatments wit...

ATP-dependent chromatin remodeling: genetics, genomics and mechanisms

Diana C. Hargreaves, Robert H. Crabtree · 2011 · Cell Research · 896 citations

Novel mutations target distinct subgroups of medulloblastoma

Giles Robinson, Matthew Parker, Tanya A. Kranenburg et al. · 2012 · Nature · 844 citations

Medulloblastoma is a malignant childhood brain tumour comprising four discrete subgroups. Here, to identify mutations that drive medulloblastoma, we sequenced the entire genomes of 37 tumours and m...

Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2

Sarah K. Knutson, Natalie M. Warholic, Tim J. Wigle et al. · 2013 · Proceedings of the National Academy of Sciences · 755 citations

Inactivation of the switch/sucrose nonfermentable complex component SMARCB1 is extremely prevalent in pediatric malignant rhabdoid tumors (MRTs) or atypical teratoid rhabdoid tumors. This alteratio...

Reading Guide

Foundational Papers

Start with Hargreaves and Crabtree (2011, 896 citations) for core mechanisms; Wiegand et al. (2010, 1647 citations) for ARID1A mutations in ovarian cancer; Wang et al. (1996, 702 citations) for SWI/SNF diversity.

Recent Advances

Northcott et al. (2017) for medulloblastoma landscapes; Sachs et al. (2019) for SMARCAD1 in retrovirus silencing; Shi et al. (2013) for leukemia maintenance.

Core Methods

Whole-genome sequencing for mutations (Robinson et al., 2012); ChIP-seq and ATAC-seq for accessibility (Hargreaves and Crabtree, 2011); EZH2 inhibitors for functional validation (Knutson et al., 2013).

How PapersFlow Helps You Research Epigenetic Regulation by Chromatin Remodelers

Discover & Search

Research Agent uses searchPapers with query 'ARID1A mutations chromatin remodeling cancer' to retrieve Wiegand et al. (2010) (1647 citations), then citationGraph reveals 50+ downstream studies on SWI/SNF in ovarian cancer, and findSimilarPapers expands to medulloblastoma cases like Northcott et al. (2017). exaSearch uncovers niche preprints on SMARCAD1 beyond OpenAlex.

Analyze & Verify

Analysis Agent applies readPaperContent to parse Hargreaves and Crabtree (2011) for mechanism details, verifies mutation frequencies via verifyResponse (CoVe) against Getz et al. (2013) datasets, and runs PythonAnalysis to plot SWI/SNF mutation rates across 10 papers using pandas, with GRADE scoring evidence strength for therapeutic claims.

Synthesize & Write

Synthesis Agent detects gaps in ARID1A-EZH2 interplay post-Knutson et al. (2013), flags contradictions between leukemia (Shi et al., 2013) and solid tumor roles, then Writing Agent uses latexEditText for figure legends, latexSyncCitations for 20-paper bibliography, and latexCompile to generate a review manuscript with exportMermaid diagrams of remodeler complexes.

Use Cases

"Extract mutation frequencies of SMARCB1 and ARID1A from endometrial and rhabdoid tumor papers, then plot with error bars."

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/matplotlib on parsed tables from Knutson et al. (2013) and Getz et al. (2013)) → CSV plot of mutation spectra with statistical significance.

"Write a LaTeX methods section reviewing SWI/SNF complex diversity with citations to Wang et al. (1996) and Hargreaves et al. (2011)."

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → polished LaTeX section with compiled PDF and synced bibliography.

"Find GitHub repos analyzing ChIP-seq data from chromatin remodeler papers like Sachs et al. (2019)."

Research Agent → paperExtractUrls (Sachs et al., 2019) → Code Discovery → paperFindGithubRepo → githubRepoInspect → curated list of 5 repos with peak-calling pipelines for remodeler binding sites.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ SWI/SNF papers: searchPapers → citationGraph → readPaperContent → GRADE grading → structured report on mutation prevalence. DeepScan applies 7-step analysis to Wiegand et al. (2010): exaSearch → verifyResponse (CoVe) → runPythonAnalysis on variant calls → checkpoint-validated summary. Theorizer generates hypotheses on ARID1A loss driving EZH2 dependency from Knutson et al. (2013) and Shain et al. (2013).

Try Doxa for Epigenetic Regulation by Chromatin Remodelers Research

Frequently Asked Questions

What defines epigenetic regulation by chromatin remodelers?

ATP-dependent enzymes like SWI/SNF complexes slide, eject, or restructure nucleosomes to expose DNA for methylation or transcription factor binding (Hargreaves and Crabtree, 2011).

What are key methods for studying remodelers in cancer?

Integrated multi-omics (WGS, RNA-seq, proteomics) map mutations and effects, as in Getz et al. (2013); ChIP-seq identifies binding, per Sachs et al. (2019).

Which papers establish ARID1A as a tumor suppressor?

Wiegand et al. (2010) report ARID1A mutations in 46/102 ovarian clear-cell carcinomas; Shain and Pollack (2013) extend to spectrum across cancers.

What are open problems in remodeler regulation?

Dynamic subunit exchanges in cancer contexts and context-specific drug resistances remain unresolved, despite insights from Wang et al. (1996) and Knutson et al. (2013).